The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multicentre randomized controlled trial

Br J Dermatol. 2015 Oct;173(4):1091-4. doi: 10.1111/bjd.13906. Epub 2015 Aug 25.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biological Products / therapeutic use*
  • Cluster Analysis
  • Combined Modality Therapy
  • Dermatologic Agents / therapeutic use*
  • Etanercept / therapeutic use*
  • Female
  • Health Status Indicators
  • Humans
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Psoriasis / drug therapy*
  • Psoriasis / psychology
  • Quality of Life*
  • Surveys and Questionnaires
  • Treatment Outcome
  • Young Adult

Substances

  • Biological Products
  • Dermatologic Agents
  • Etanercept

Associated data

  • NTR/NTR1364